Kanazawa University Discovers Gastric Cancer Metastasis Mechanism
Analysis based on 7 articles · First reported Feb 25, 2026 · Last updated Mar 18, 2026
This medical breakthrough offers promising new therapeutic strategies for gastric cancer, potentially leading to the development of new drugs and treatments. This could significantly impact the biotechnology and pharmaceutical sectors, creating new market opportunities and improving patient outcomes.
Researchers at Kanazawa University, led by Masanobu Oshima, have discovered a crucial mechanism by which gastric cancer spreads to the liver. Their study, published in Nature Communications, reveals that ligand-dependent Wnt signaling in the tumor microenvironment activates stromal fibroblasts, leading to hyaluronan production. This hyaluronan creates a supportive niche that enables cancer cells to survive and grow in the liver. The findings suggest new therapeutic strategies, including targeting Wnt signaling, inhibiting hyaluronan production, or disrupting the metastatic niche, offering hope for better prevention and treatment of metastatic gastric cancer. The research was supported by the Japan===Ministry of Education, Culture, Sports, Science and Technology (MEXT) and the Japan===Japan Agency for Medical Research and Development (AMED) in Japan.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard